Dr. Richardus Vonk leads the Oncology Statistics and Data Management at Bayer AG. He is located in Berlin, Germany, and has over 30 years of experience in research and pharmaceutical development. Richardus regularly speaks about quantitative decision making in a changing pharmaceutical environment. His current scientific interest is in method development for early pharmaceutical development, biomarker development, and the transition between different phases of clinical development, all with a clear focus on quantitative decision making. Richardus has an MSc in Mathematics from the University of Nijmegen, and obtained his PhD at the Free University Berlin.